Potentials and Challenges in Development of Vesicular Phospholipid Gel as a Novel Dermal Vehicle for Thymol

<b>Background/Objectives:</b> Thymol, one of the main compounds of thyme essential oil, has shown promising effects in treating various skin disorders owing to its anti-inflammatory, antimicrobial and antioxidative activities. Due to its limited solubility in water, thymol is commonly used in higher concentrations to achieve a suitable therapeutic effect, which can consequently lead to skin irritation. To overcome these limitations, we incorporated thymol into a vesicular phospholipid gel (VPG), a novel semisolid dermal vehicle consisting of highly concentrated dispersion of phospholipid vesicles (liposomes). <b>Methods:</b> Thymol was successfully loaded into two VPGs differing in bilayer fluidity, which were characterized for the physicochemical and rheological properties, storage stability, in vitro release, ex vivo skin permeability, in vitro compatibility with epidermal cells, wound healing potential, and antibacterial activity against skin-relevant bacterial strains. <b>Results:</b> High pressure homogenization method enabled preparation of VPG-liposomes of neutral surface charge in the size range 140-150 nm with polydispersity indexes below 0.5. Both types of VPGs exhibited viscoelastic solid-like structures appropriate for skin administration and ensured skin localization of thymol. Although both types of VPGs enabled prolonged release of thymol, the presence of cholesterol in the VPG increased the rigidity of the corresponding liposomes and further slowed down thymol release. <b>Conclusions:</b> Loading of thymol into VPGs significantly reduced its cytotoxicity toward human keratinocytes in vitro even at very high concentrations, compared to free thymol. Moreover, it facilitated in vitro wound healing activity, proving its potential as a vehicle for herbal-based medicines. However, the antibacterial activity of thymol against <i>Staphylococcus aureus</i> and methicillin-resistant <i>S. aureus</i> was hindered by VPGs, which represents a challenge in their development.

Authors

Institutions

Publication Details

Journal
Pharmaceutics
Published
2025-06-29
DOI
https://doi.org/10.3390/pharmaceutics17070854
Citations
2
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
1.58

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Potentials and Challenges in Development of Vesicular Phospholipid Gel as a Novel Dermal Vehicle for Thymol

Jasmina Lovrić, Sabina Keser, Zora Rukavina, Maja Šegvić Klarić et al.
2 citations
Pharmaceutics
Advancements in Transdermal Drug Delivery
1.58
article

Potentials and Challenges in Development of Vesicular Phospholipid Gel as a Novel Dermal Vehicle for Thymol

Jasmina Lovrić, Sabina Keser, Zora Rukavina, Maja Šegvić Klarić, Darija Stupin Polančec, Gordana Maravić-Vlahoviček, Željka Vanić, Marica Jozić, Lea Pavlović-Mitrović, Magda Vodolšak, Kristina Kranjčec
article en
2 citations

Abstract

<b>Background/Objectives:</b> Thymol, one of the main compounds of thyme essential oil, has shown promising effects in treating various skin disorders owing to its anti-inflammatory, antimicrobial and antioxidative activities. Due to its limited solubility in water, thymol is commonly used in higher concentrations to achieve a suitable therapeutic effect, which can consequently lead to skin irritation. To overcome these limitations, we incorporated thymol into a vesicular phospholipid gel (VPG), a novel semisolid dermal vehicle consisting of highly concentrated dispersion of phospholipid vesicles (liposomes). <b>Methods:</b> Thymol was successfully loaded into two VPGs differing in bilayer fluidity, which were characterized for the physicochemical and rheological properties, storage stability, in vitro release, ex vivo skin permeability, in vitro compatibility with epidermal cells, wound healing potential, and antibacterial activity against skin-relevant bacterial strains. <b>Results:</b> High pressure homogenization method enabled preparation of VPG-liposomes of neutral surface charge in the size range 140-150 nm with polydispersity indexes below 0.5. Both types of VPGs exhibited viscoelastic solid-like structures appropriate for skin administration and ensured skin localization of thymol. Although both types of VPGs enabled prolonged release of thymol, the presence of cholesterol in the VPG increased the rigidity of the corresponding liposomes and further slowed down thymol release. <b>Conclusions:</b> Loading of thymol into VPGs significantly reduced its cytotoxicity toward human keratinocytes in vitro even at very high concentrations, compared to free thymol. Moreover, it facilitated in vitro wound healing activity, proving its potential as a vehicle for herbal-based medicines. However, the antibacterial activity of thymol against <i>Staphylococcus aureus</i> and methicillin-resistant <i>S. aureus</i> was hindered by VPGs, which represents a challenge in their development.

PharmaceuticsVol. 17(7)
University of Zagreb (HR), Pliva (Croatia) (HR), University of Slavonski Brod (HR)
Sveučilište u Zagrebu, European Regional Development Fund
Clean water and sanitation
Openalex Percentile: Top 16%
Advancements in Transdermal Drug Delivery
1.58
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.